Jump to:Page Content
Stand out from the crowd! Advertise in Trial to reach a national audience of major decision-makers who are looking for products and services to improve their legal practices.
Allison Torres Burtka
In a case brought by a woman who alleged that she developed a severe neurological disorder from taking metoclopramide, the generic version of the brand-name drug Reglan, the appeals court agreed with arguments by the Center for Constitutional Litigation that federal law does not preempt a failure-to-warn claim against a generic drug manufacturer.